A prospective multicenter phase II study evaluating multimodality treatment of patients with peritoneal carcinomatosis arising from appendiceal and colorectal cancer: the COMBATAC trial

BACKGROUND: Peritoneal carcinomatosis is regarded as a common sign of advanced tumor stage, tumor progression or local recurrence of appendiceal and colorectal cancer and is generally associated with poor prognosis. Although survival of patients with advanced stage CRC has markedly improved over the...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Glockzin, Gabriel, Rochon, Justine, Arnold, Dirk, Lang, Sven A, Klebl, Frank, Zeman, Florian, Koller, Michael, Schlitt, Hans J, Piso, Pompiliu
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2013
Témata:
Study Protocol
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3575316/
https://ncbi.nlm.nih.gov/pubmed/23391248
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2407-13-67
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky